Pricing Log in Create free account

Greenwich LifeSciences, Inc. (GLSI) vs Korro Bio, Inc. (KRRO)

Greenwich LifeSciences, Inc. and Korro Bio, Inc. are both Biotechnology companies. Greenwich LifeSciences, Inc. and Korro Bio, Inc. are of similar size ($222.7M and $202.5M). Across the 9 metrics below, Korro Bio, Inc. leads on 5 and Greenwich LifeSciences, Inc. on 4.

Valuation

Metric GLSI KRRO Biotechnology median
P/E n/m n/m 10.60
P/S n/m 40.65 9.40
P/B 71.16 2.52 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales n/m 25.53 9.02
Earnings yield (9.95%) (67.80%) (32.88%)
Free cash flow yield (5.63%) (26.27%) (23.13%)

Profitability

Metric GLSI KRRO Biotechnology median
Gross margin 0.00% 100.00% 68.51%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (986.31%) (97.69%) (51.96%)
Return on assets (374.46%) (62.03%) (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric GLSI KRRO Biotechnology median
Revenue growth (TTM) — (81.87%) 6.76%
EPS growth (last fiscal year) (6.72%) (33.19%) 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric GLSI KRRO Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 1.54 9.55 4.97
Net debt to EBITDA 0.32 0.64 1.01

Dividend

Metric GLSI KRRO Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric GLSI KRRO Biotechnology median
Market cap 222.67m 202.45m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack